journal article·2015-10

The role of ROS generation from magnetic nanoparticles in an alternating magnetic field on cytotoxicity

Robert J. Wydra, Piotr G. Rychahou, B. Mark Evers, Kimberly W. Anderson, Thomas D. Dziubla, J. Zach Hilt

Acta Biomaterialia· Volume 25
Publisher page

Abstract

Monosaccharide coated iron oxide nanoparticles were developed to selectively target colon cancer cell lines for magnetically mediated energy delivery therapy. The nanoparticles were prepared using a coupling reaction to attach the glucose functional group to the iron oxide core, and functionality was confirmed with physicochemical characterization techniques. The targeted nanoparticles were internalized into CT26 cells at a greater extent than non-targeted nanoparticles, and the nanoparticles were shown to be localized within lysosomes. Cells with internalized nanoparticles were exposed to an AMF to determine the potential to delivery therapy. Cellular ROS generation and apoptotic cell death was enhanced with field exposure. The nanoparticle coatings inhibit the Fenton-like surface generation of ROS suggesting a thermal or mechanical effect is more likely the source of the intracellular effect, unless the nanoparticle coating is unstable in the cellular environment. Statement of significance This is the first study to assess glucose coated MNPs for the delivery of MagMED therapy. With exposure of an AMF, the glucose-coated nanoparticles displayed a significant increase in cellular ROS and apoptotic cell death with no measurable increase in media temperature. To determine the mechanism of toxicity, we investigated the surface generation of ROS through Fenton-like chemistry. The coated systems displayed negligible ROS generation compared to uncoated nanoparticles. These observations suggest the cellular ROS measured is attributed to a thermal or mechanical effect of the internalized nanoparticles. In summary, this manuscript reports on some new insights as to the mechanism of MagMED therapies, which are of high interest to the biomaterials and cancer nanomedicine fields.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Magnetic Properties and Synthesis of Ferrites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications10.2217/nnm.10.114 ↗
2. Progress in functionalization of magnetic nanoparticles for applications in biomedicine10.1088/0022-3727/42/22/224003 ↗
3. Medical application of functionalized magnetic nanoparticles10.1263/jbb.100.1 ↗
4. Magnetic nanoparticles in MR imaging and drug delivery10.1016/j.addr.2008.03.018 ↗
5. Developments for the minimally invasive treatment of tumours by targeted magnetic heating10.1088/0953-8984/18/38/S28 ↗
6. Exploiting the enhanced permeability and retention effect for tumor targeting10.1016/j.drudis.2006.07.005 ↗
7. Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science10.1016/j.bbagen.2005.12.001 ↗
8. Targeted nanoparticles for detecting and treating cancer10.1002/ddr.20069 ↗
9. Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications10.1016/j.actbio.2014.01.025 ↗
10. Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs10.1021/nn205070h ↗
11. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise10.1021/nn201822b ↗
12. Magnetic fluid hyperthermia: advances, challenges, and opportunity10.3109/02656736.2013.837200 ↗
13. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?10.1080/02656730110116713 ↗
14. Monitoring iron oxide nanoparticle surface temperature in an alternating magnetic field using thermoresponsive fluorescent polymers10.1063/1.3680532 ↗
15. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity10.1021/ja104683w ↗
16. Suppressing iron oxide nanoparticle toxicity by vascular targeted antioxidant polymer nanoparticles10.1016/j.biomaterials.2013.08.025 ↗
17. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress10.2147/IJN.S13244 ↗
18. Effective elimination of cancer stem cells by magnetic hyperthermia10.1021/mp400015b ↗
19. Comparison of a new immobilized Fe3+ catalyst with homogeneous Fe3+–H2O2 system for degradation of 2,4-dinitrophenol10.1002/jctb.3699 ↗
20. Cancer stem cells survival skills10.1038/nrc2614 ↗
21. Accelerated generation of free radicals by iron oxide nanoparticles in the presence of an alternating magnetic field10.1039/C4RA13564D ↗
22. Glyconanoparticles as multifunctional and multimodal carbohydrate systems10.1039/c2cs35420a ↗
23. Glyco-nanomaterials: translating insights from the “Sugar-Code” to biomedical applications10.2174/092986711795656144 ↗
24. Glycopolymer-coated iron oxide nanoparticles: shape-controlled synthesis and cellular uptake10.1039/C4TB00852A ↗
25. Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles10.1016/j.biomaterials.2010.12.031 ↗
26. Glycoconjugated amphiphilic polymers via click-chemistry for the encapsulation of quantum dots10.1021/la402826f ↗
27. Engineering biofunctional magnetic nanoparticles for biotechnological applications10.1039/c0nr00104j ↗
28. Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-glucose modified SPIOs10.1016/j.ejrad.2011.03.013 ↗
29. Preparation, characterization of 2-deoxy-d-glucose functionalized dimercaptosuccinic acid-coated maghemite nanoparticles for targeting tumor cells10.1007/s11095-011-0653-9 ↗
30. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer10.1088/0957-4484/22/28/285101 ↗
31. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver10.1097/00006231-200009000-00002 ↗
32. Enhancing remote controlled heating characteristics in hydrophilic magnetite nanoparticles via facile co-precipitation10.1016/j.jmmm.2009.09.050 ↗
33. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells10.2147/IJN.S10458 ↗
34. Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake10.1021/nn204543c ↗
35. Physicochemical origin for free radical generation of iron oxide nanoparticles in biomicroenvironment: catalytic activities mediated by surface chemical states10.1021/jp3101392 ↗
36. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials10.1016/j.biomaterials.2009.04.009 ↗
37. Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields10.1021/nn4007048 ↗
38. Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation10.1021/nn406302j ↗
39. Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation10.1016/j.bbrc.2012.07.108 ↗
40. Free radicals, metals and antioxidants in oxidative stress-induced cancer10.1016/j.cbi.2005.12.009 ↗
41. Exploiting oxidative microenvironments in the body as triggers for drug delivery systems10.1089/ars.2013.5754 ↗
42. ROS function in redox signaling and oxidative stress10.1016/j.cub.2014.03.034 ↗
43. Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering10.1371/journal.pone.0085835 ↗
44. Limits of localized heating by electromagnetically excited nanoparticles10.1063/1.2335783 ↗
45. Remote control of ion channels and neurons through magnetic-field heating of nanoparticles10.1038/nnano.2010.125 ↗
46. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes10.1021/nl2001499 ↗
47. Iron-dependent lysosomal destabilization initiates silica-induced apoptosis in murine macrophages10.1016/j.toxlet.2005.05.002 ↗
48. Regulation of apoptosis-associated lysosomal membrane permeabilization10.1007/s10495-009-0452-5 ↗
49. Radiation-induced lysosomal iron reactivity: implications for radioprotective therapy10.1080/15216540600755998 ↗
50. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture10.3390/ijms13055554 ↗